Replies to post #102986 on Ayala Pharmaceuticals Inc (ADXS)

[raja48185]

As of October 31, 2019, Advaxis had cash and cash equivalents of $32.4 million.

and the company has enough money to last till early 2021 ? (extending our cash runway until early 2021 as they put it on the PR dated Oct.24)

Wait till end/anytime of 1Q 2020 for the next 'Business Update Shock'

[ubmmg]

Cash and CEs as of 7/31/19 : $41.8MM
Cash and CEs as of 10/31/19: $32.4MM
Cash burn rate per quarter: $9.4MM
Annualized rate: $37.6MM (close to what they say).
Well, with this cash burn rate they are out of cash by mid-August 2020. Why they keep saying "we cash into early 2021"? Even though they mean a financial year that starts 11/1/2020 -- not a calendar year -- it's almost three months shorter than they estimate. If they are to replenish their coffers by 6 months before it's on E, the raise will be no later than March, but likely in February 2020. Will they have a solid data by then? Not likely. So, how they are going to pull this off then?